Crispr Therapeutics Ag (CRSP) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Crispr Therapeutics Ag  (NASDAQ: CRSP)


Crispr Therapeutics Ag's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Crispr Therapeutics Ag's ROI in the second quarter of 2026?
Crispr Therapeutics Ag recorded a cumulative net loss of $-451 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -19.3%.

Within the Healthcare sector 293 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2571 to 3402.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 12.75 % 2.08 % -7.21 % -6.42 % -3.89 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2,518 2,590 2,116 2,126 1,925
Return On Investment (TTM) -19.3 % -25.97 % -28.32 % -23.67 % -22.56 %
CRSP's Overall Ranking # 3402 # 2571 # 2339 # 3034 # 2971
Seq. Investment Change TTM 6.77 % 6.61 % -0.46 % -0.48 % -3.34 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -451 -569 -582 -488 -468

CRSP Company Profile >> Back to CRSP Roi Comparisons >> See Annual CRSP Return On Investment



Return On Investment CRSP's Ranking
Within: No.
Industry # 31
Sector # 294
Overall # 3402

Return On Investment Statistics
High Average Low
21.99 %
-15.75 %
-42.64 %
(Jun 30 2021)   (Jun 30 2019)







Financial Statements
Crispr Therapeutics Ag's II. Quarter Investments $ 2,518 Millions CRSP's Balance sheet
Crispr Therapeutics Ag's II. Quarter Income $ -91 Millions Quarterly CRSP's Income Statement
CRSP's Income by Division See CRSP's Income by Division


CRSP Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,928 2,154 2,121 2,122 2,632
Y / Y Investment Growth -10.5 % 1.58 % -0.06 % -19.38 % 51.81 %
Net Income in Millions -582 -366 -154 -650 378
Y / Y Net Income Growth - - - - -
Annual Return On Investment -30.17 % -17 % -7.24 % -30.64 % 14.35 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CRSP's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CRSP's Competitors
Subscribers only: Roi for Crispr Therapeutics Ag's Suppliers
Subscribers only: Return On Investment for CRSP's Customers

Other Ratios
CRSP's Roa CRSP's Inventory Turnover Ratio CRSP's Growth Rates CRSP's Dividend Statistics
CRSP's Profitability Ratios CRSP's Asset Turnover Ratio CRSP's Dividend Growth
CRSP's Roe CRSP's Valuation Ratios CRSP's Financial Strength Ratios CRSP's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T18:22:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.